The place of chondroprotectors in the treatment of osteoarthritis of the spine
https://doi.org/10.21518/2079-701X-2016-4-42-47
Abstract
Osteoarthritis is the major nosological form representing degenerative joint disease, characterized by chronic, steadily progressive course. The disease is primarily caused by an imbalance between the anabolic and catabolic processes, especially in the hyaline cartilage. Administration of structure-modifying medications (or chondroprotectors) for the treatment of osteoarthritisis is pathogenetically substantiated, contributes to a significant reduction of the NSAIDs intake and considerably reduces the risk of side effects. Currently, the most thoroughly studied chondroprotectors are chondroitin
References
1. Цементит С.А. Дифференциальная диагностика в неврологии и нейрохирургии. Под ред. Е.И. Гусева. М.: ГЭОТАР-Медиа, 2005. 368 с.
2. Вознесенская Т.П Боли в спине: взгляд невролога. Consilium medicum, 2006, 8(2): 257-261.
3. Мендель О.И., Никифоров А.С. Дегенеративные заболевания позвоночника, их осложнения и лечение. РМЖ, 2006, 14(4): 34-39.
4. Справочник по формулированию клинического диагноза болезней нервной системы. Под ред. B.П. Штока, О.С. Левина. М.: МИА, 2006. 520 с.
5. Пизова Н.В. Костно-суставные боли в грудном отделе позвоночника и грудной клетке. Медицинский совет, 2014, 4: 88-93.
6. Пизова Н.В. У Вашего пациента боль в нижней части спины. Что делать? Неврология, нейроп-сихиатрия, психосоматика. 2013, 1:69-74
7. Зборовский А.Б., Мозговая Е.Э. Алфлутоп: опыт многолетнего клинического применения. Фарматека, 2006, 19: 35-40.
8. Шостак НА. Современные подходы к терапии боли в нижней части спины. Consilium mеdicum, 2003, 5(8): 457-461.
9. Воробьева О.В. Боли в спине. РМЖ, 2003, 10: 594-598.
10. Шостак Н.А. Современные подходы к терапии боли в нижней части спины. Consilium medicum, 2003, 8: 27-29.
11. Насонов Е.Л., Лазебник Л.Б., Беленков Ю.Н. и др. Применение нестероидных противовоспалительных препаратов. Клинические рекомендации. М.: Алмаз, 2006.
12. Подчуфарова Е.В. Хронические боли в спине: патогенез, диагностика, лечение. Русский медицинский журнал. 2003, 11(25): 1395-1401.
13. Неспецифическая боль в нижней части спины: клинические рекомендации. Под ред. Ш.Ф. Эрдеса. М.: КомплектСервис, 2008. 70 с.
14. Парфенов В.А. Причины, диагностика и лечение боли в нижней части спины. Неврология, ней-ропсихиатрия и психосоматика, 2009, 1: 19-22.
15. Веселовский В.П. Практическая вертебронев-рология и мануальная терапия. Рига, 1991. С. 30-145.
16. Вознесенская Т.П Боли в спине и конечностях. Болевые синдромы в неврологической практике. Под ред. А.М. Вейна. М.: Медпресс, 1999. C. 217-83.
17. Waddel G. The back pain revolution. Edinburg: Churchill Livingstone, 1998.
18. Bogduk N, McGuirk B. Medical management of acute and chronic low back pain. Amsterdam: Elsevier, 2002.
19. Hall H. Back pain. JH Noseworthy (eds). Neurological therapeutics: principles and practice. London: Martin Dunitz, 2003.
20. Morreale P et al. Diagnosis and treatment of pain of vertebral origin. Baltimore: Williams&Wilkins, 1996.
21. Verbruggen G. Chondroprotective drugs in degenerative joint diseases. Rheumatol. (Oxford), 2006, 45(2): 129-138.
22. Hochberg MC, Dougados M. Pharmacological therapy of osteoarthritis. Best. Pract. Res. Clin. Rheumatol, 2001, 15(15): 583-593.
23. Ubelhart D, Malaise M, Marcolongo R et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomised, double-blind, multicentre study versus placebo. Osteoarthritis and Cartilage, 2004: 269-276.
24. De los Reyes GC, Koda RT, Lien EJ. Glucosamin and chondroitin sulfates in the treatment of osteoarthritis: a survey. Prog. Drug. Res., 2000, 55: 81-103.
25. McAlindon Т, LaValley М. Glucosamin and Chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanaly-sis. JAMA, 2000, 283: 1469-1475.
26. Simanek V, Kren V, Ulrichova J, Gallo J. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals? Biomed. Papers., 2005, 149 (1): 51-56.
27. Wim J van Blitterswijk, Jos CM van de Nes, Paul IJM. Wuisman Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: Biochemical rationale and case report. BMC Complementary and Alternative Medicine, 2003, 3: 2.
28. Towheed TE, Anastassiades TP. Glucosamine and chondroitin for treating symptoms of oste-oarthritis. Evidence is widely touted but incomplete. JAMA, 2000, 283: 1483-1484.
29. Leeb BF, Schweitzer H, Montag K, Smolen JS. A meta-analysis of chondroitin sulfate in the treatment of osteoarthritis. J. Rheumatol., 2000, 27: 205-211.
30. Richy F, Bruyere O, Ethgen O. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch. Intern. Med., 2003, 163: 1514-1522.
31. Towheed TE, Maxwell L, Anastassiades TP. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev, 2005. CD002946-CD002946.
32. Ronca F, Palmieri L, Panicucci P, Ronca G. Antiinflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage, 1998, 6: S14-S21.
33. Lippiello L, Woodward J, Karpman R, Hammad TA. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sul-fate. Clin Orthop Relat Res, 2000, 381: 229-240.
34. Volpi N. Anti-inflammatory activity of chondroi-tin sulphate: new functions from an old natural macromolecule. Inflammopharmacology. 2011, 19(6): 299-306.
35. Bauerova K, Ponist S, Kuncirova V et al. Chondro-itin sulfate effect on induced arthritis in rats. Osteoarthritis Cartilage,. 2011, 19(11): 1373-9.
36. Taniguchi S, Ryu J, Seki M et al. Long-term oral administration of glucosamine or chondroitin sulfate reduces destruction of cartilage and up-regulation of MMP-3 mRNA in a model of spontaneous osteoarthritis in Hartley guinea pigs. J Orthop Res, 2012, 30(5): 673-8.
37. Schneider H, Maheu E, Cucherat M. Symptom-modifying effect of chondroitin sulfate in knee osteoarthritis: a meta-analysis of randomized placebo-controlled trials performed with struc-tumR. Open Rheumatol J, 2012, 6: 183-9.
38. Sawitzke AD, Shi H, Finco MF et al. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT. Ann Rheum Dis, 2010, 69(8): 1459-64.
39. Michel BA, Stucki G, Frey D et al. Chrondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum, 2005, 52: 779-786.
40. Martel-Pelletier J, Roubille C, Abram F et al. First-line analysis of the effects of treatment on progression of structural changes in knee osteoar-thritis over 24 months: data from the osteoarthri-tis initiative progression cohort. Ann Rheum Dis, 2013. doi: 10.1136/annrheumdis-2013-203906.
41. Hochberg M, Chevalier X, Henrotin Y et al. Symptom and structure modification in osteo-arthritis with pharmaceutical-grade chondroit-in sulfate: what's the evidence? Curr Med Res Opin, 2013, 29(3): 259-67.
42. Leffler CT, Philippi AF, Leffler SG et al. Glucosa-mine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomised, double-blind, placebo-controlled pilot study. Mil. Med., 1999, 164 (2): 85-91.
43. McAlindon Т, LaValley M. Glucosamin and Chondroitin for treatment of osteoarthritis: a systematic quality assessment and metaanaly-sis. JAMA, 2000, 283: 1469-1475.
44. Register JY, Deroisy R, Rovati LC et al. Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet, 2001, 357: 251-256.
45. Hall H. Back pain. Neurological therapeutics: principles and practice. Ed. by H. Hall, J.H. Noseworthy. London: Martin Dunitz, 2003.
46. Simanek V, Kren V, Ulrichova J, Gallo J. The efficacy of glucosamine and chondroitin sulfate in the treatment of osteoarthritis: are these saccharides drugs or nutraceuticals? Biomed. Papers., 2005. 149(1): 51-56.
47. Tiraloche G, Girard C, Chouinard L et al. Effect of oral glucosamine on cartilage degradation in a rabbit model of osteoarthritis. Arthritis Rheum, 2005, 52: 1118-1128.
48. Towheed TE, Anastassiades TP. Glucosamine and chondroitin for treating symptoms of oste-oarthritis. Evidence is widely touted but incomplete. JAMA, 2000, 283: 1483-1484.
49. Wim J van Blitterswijk, Jos CM van de Nes, Paul IJM. Wuisman. Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: Biochemical rationale and case report. BMC Complementary and Alternative Medicine, 2003, 3: 2.
50. Tsementit S.A. Differential Diagnosis in Neurology and Neurosurgery. Ed. by E.I. Gusev. М.: GEOTAR-Media, 2005. 368 p.
51. Voznesenskaya T.G. Back pain: a neurologist's view. Consilium Medicum, 2006, 8(2): 257-261.
52. Mendel O.I., Nikiforov A.S. Degenerative diseases of the spine, complications and treatment. RMZ, 2006, 14(4): 34-39.
53. Guide on clinical diagnostic formulation: diseases of the nervous system. Ed. by V.P. Shtok, O.S. Levin. М.: MIA, 2006. 520 p.
54. Pizova N.V. Osteoarticular pain in the thoracic spine and chest. Meditsinsky Sovet, 2014, 4: 88-93.
55. Pizova N.V. Your patient has lower back pain. What should be done? Nevrologia, Neyropsikhiatria i Psikhosomatika. 2013, 1:69-74
56. Zborovskiy A.B., Mozgovaya E.E. Alflutop: long-term clinical experience. Farmateka, 2006, 19: 35-40.
57. Shostak N.A. Modern approaches to the treatment of lower back pain. Consilium mеdicum, 2003, 5(8): 457-461.
58. Vorobyova O.V. Back pain. RMZ, 2003, 10: 594-598.
59. Shostak NA. Modern approaches to the treatment of lower back pain. Consilium Medicum, 2003, 8: 27-29.
60. Nasonov E.L., Lazebnik L.B., Belenkov Y.N. et al. Use of nonsteroidal antiinflammatory drugs. Clinical guidelines. М.: Almaz, 2006.
61. Podchufarova E.V. Chronic back pain: pathogenesis, diagnosis and treatment. Russkiy Meditsinskiy Zhurnal. 2003, 11(25): 1395-1401.
62. Nonspecific lower back pain: clinical guidelines. Ed. by S.F. Erdes. М.: ComplectService, 2008. 70 p.
63. Parfyonov V.A. Causes, diagnosis and treatment of chronic nonspecific low back pain. Nevrologia, Neyropsikhiatria i Psickhosomatika, 2009, 1: 19-22.
64. Veselovsky V.P. Practical vertebroneurology and manual therapy. Riga, 1991. P. 30-145.
65. Voznesenskaya T.G. Pain in the back and limbs. Pain syndromes in neurological practice. Ed. by A.M. Wayne. М.: MedPress, 1999. P. 217-83.
Review
For citations:
Pizova NV. The place of chondroprotectors in the treatment of osteoarthritis of the spine. Meditsinskiy sovet = Medical Council. 2016;(4):42-47. (In Russ.) https://doi.org/10.21518/2079-701X-2016-4-42-47
Views:
763
Email this article 